Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 13, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 4, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record35718 flagged findings
Reported transactions (Form 4)80since Apr 14, 2023 · and 7 other holdings
Corporate events (8-K)30since Jan 5, 2022
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Listing notice in force
The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of May 15, 2026).
Deadline: Nov 7, 2026
- minimum bid price · Nasdaq, rule 5450(a)(1) · notice of May 11, 2026 · pending · deadline Nov 7, 2026 (derived from the rule, not confirmed in the text)
Of the 30 issuers that received this notice 1 to 2 years ago, within the following 365 days 16 regained compliance, 23 did a reverse split and 1 filed a Form 25 (delisting). An issuer can be in more than one group.
Measured on our own SEC documents: the cohort is the issuers whose notices we read, not the whole market. Historical distribution, not a prediction.
The 25 most recent filings (of 357)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · RA Capital Management, L.P. · 9.9% · event on Jun 30, 26 · amendment
- Aug 13, 2610-Q ↗Quarterly report
- Aug 13, 268-K ↗Current report · Results
- Aug 4, 26Form 4 ↗Insider transaction
- Aug 4, 26Form 3 ↗Insider transaction
- Aug 4, 268-K ↗Current report · A senior executive left or was appointed
- Jul 31, 26SCHEDULE 13G/A ↗Passive stake · Vanguard Capital Management · 4.5% · event on Jun 30, 26 · amendment
- Jul 8, 26Form 3 ↗Insider transaction
- Jun 30, 268-K ↗Current report · A senior executive left or was appointed
Insider transaction · 9 Form 4 filingsshow all 9hide
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 1, 26Form 4 ↗Insider transaction
- Jun 1, 26Form 4 ↗Insider transaction
- Jun 1, 26Form 4 ↗Insider transaction
- Jun 1, 26Form 4 ↗Insider transaction
- Jun 1, 26Form 4 ↗Insider transaction
- Jun 1, 26Form 4 ↗Insider transaction
357 filings on record, the oldest from May 26, 21.
Listing the 25 most recent filings of the 357 on record.
41611
- Aug 4, 26A senior executive left or was appointed8-K 5.02 ↗
- Jun 30, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- May 15, 26Listing notice (8-K 3.01)+3 more in the same filing8-K 3.01 ↗
- Jan 2, 26A material agreement was terminated+4 more in the same filing8-K 1.02 ↗
- Oct 27, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Oct 17, 25Sold unregistered shares+3 more in the same filing8-K 3.02 ↗
- Jun 26, 25Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- May 20, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- May 6, 25Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Apr 30, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 9, 25Auditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
- Sep 11, 24Auditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
11 older filings not shown · The record reaches back to Nov 12, 21.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Nov 1, 23Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
The full record holds 4 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- MIR A IMRAN22.1%Oct 23, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Srinivas Akkaraju9.9%May 26, 26SCHEDULE 13D/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- South Cone Investments Limited Partnership4.9%Oct 20, 25SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Raymond Debbane10.0%Oct 16, 25SCHEDULE 13G ↗8 co-filers on this document — the figure is the largest single stake, not their sum.
- RA Capital Management, L.P.9.9%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- AWM Investment Company, Inc.9.9%Dec 31, 25SCHEDULE 13G ↗
- The Vanguard Group5.2%Dec 31, 25SCHEDULE 13G ↗
- Armistice Capital, LLC5.0%Sep 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 3 more holdershide
- Vanguard Capital Management4.5%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
- SymBiosis Capital Partners, LLC4.4%Mar 27, 26SCHEDULE 13G/A ↗1 earlier filing
- Orca Capital AG4.3%Jul 22, 25SCHEDULE 13G/A ↗1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Jul 21, 26Buy$25KMIR A IMRAN↗
- Jul 17, 26Buy$25KTalat ImranChief Executive Officer↗
- Mar 27, 26Sell$301Alireza JavadiChief Technical Officer↗
- Oct 23, 25Buy$1.3MMIR A IMRAN↗
- Oct 21, 25Sell$11.1MSouth Cone Investments Limited Partnership↗
- Oct 20, 25Sell$4.6MSouth Cone Investments Limited Partnership↗
- Dec 27, 24Sell$11KTalat ImranChief Executive Officer↗
- Dec 13, 24Buy$30KKate McKinleyChief Business Officer↗
- Dec 9, 24Buy$20KTalat ImranChief Executive Officer↗
- Oct 15, 24Sell$8.4MSouth Cone Investments Limited Partnership↗
- Oct 15, 24Sell$1.7MSouth Cone Investments Limited Partnership↗
- Dec 6, 23Buy$23KTalat ImranChief Executive Officer↗
There are 19 more transactions in this stretch.
Stock compensation, tax and giftsshow the 9 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Sep 27, 26Tax$235Alireza JavadiChief Technical Officer↗
- Sep 27, 26Tax$6KTalat ImranChief Executive Officer↗
- Jun 27, 26Tax$6KTalat ImranChief Executive Officer↗
- Jun 27, 26Tax$229Alireza JavadiChief Technical Officer↗
- Mar 27, 26Tax$7KTalat ImranChief Executive Officer↗
- Mar 22, 26Tax$10KTalat ImranChief Executive Officer↗
- Dec 27, 25Tax$11KTalat ImranChief Executive Officer↗
- Sep 27, 25Tax$4KTalat ImranChief Executive Officer↗
- Jun 27, 25Tax$5KTalat ImranChief Executive Officer↗
The full record holds 80 transactions and goes back to Dec 29, 22.
Its sector and its market
Rani Therapeutics Holdings Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
- QuidelOrtho Corporation QDEL
- Quince Therapeutics, Inc. QNCX
- RadNet Inc. RDNT
- Rallybio Corporation RLYB
- Ramsay Générale de Santé SA GDS
- Rapid Micro Biosystems, Inc. RPID
- Rapport Therapeutics Inc. RAPP
- Recordati Industria Chimica e Farmaceutica S.p.A. 0KBS
- Recursion Pharmaceuticals, Inc. RXRX
- Redcare Pharmacy N.V. RDC
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Rani Therapeutics Holdings Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Rani Therapeutics Holdings Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 357 documents on file, from May 26, 2021 to Sep 29, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.